BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 14, 2013
View Archived Issues
Companies enter collaboration to develop Tregitope immune-modulating technology
Read More
Boston Scientific set to launch Promus Premier stent system in Europe
Read More
Japanese authorities remove condition for approval from Abraxane
Read More
Priority review granted to Bayer's NDA for radium-223
Read More
Amylin Pharmaceuticals patents new fusion proteins
Read More
GlaxoSmithKline presents novel TRPV4 antagonists
Read More
GlaxoSmithKline discloses novel tyrosine-protein kinase inhibitors
Read More
AstraZeneca synthesizes new inhibitors of mutated forms of EGFR
Read More
Pfizer designs new glucagon receptor antagonists
Read More
Xenetic Biosciences signs research agreement
Read More
ALX-0061 demonstrates good efficacy and safety in RA patients
Read More
Agilent Technologies and Sera Prognostics form partnership
Read More
Dako and Pfizer to collaborate on companion diagnostics
Read More
Peregrine Pharmaceuticals reports results from phase II bavituximab trial
Read More
Xencor begins phase Ib/IIa trial of XmAb-5871
Read More
GGF2 enhances post-stroke recovery of sensorimotor functions in vivo
Read More
Prolor Biotech's hGH-CTP receives orphan drug designation in Europe
Read More
Phase III Fibrocaps trial achieves safety milestone
Read More
Phase III study finds no benefit for DP-b99 in acute ischemic stroke
Read More
Lundbeck reflects on highlights of 2012
Read More
Novo Nordisk gains price approval in Japan for once-daily basal insulin
Read More
EMA grants orphan designation to BHR Pharma's investigational agent for traumatic brain injury
Read More
Photoimmunotherapy enhances accumulation of nanosized chemotherapy in tumors
Read More
Lentigen obtains FDA orphan designation for novel gene therapy for glioblastoma multiforme
Read More